This inventor holds 1 USPTO granted patent. Top assignee: Infotech Soft, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Ray Mathew Bradley: Innovator in Radiogenomics
Introduction
Ray Mathew Bradley is a notable inventor based in Miami, Florida. He has made significant contributions to the field of cancer research through his innovative work in radiogenomics. His expertise lies in developing methods that enhance the visualization of cancer subtype features, which can lead to improved patient outcomes.
Latest Patents
Ray Mathew Bradley holds a patent for a groundbreaking invention titled "Radiogenomics for cancer subtype feature visualization." This patent describes a computer-implemented method and system designed to identify and visualize features correlated with various cancer subtypes. The process involves receiving a set of medical images that represent an area including a patient's lesion. It applies a classification model trained on lesions with known pathology, mathematically combining the model's learned weights with the medical images to produce a score indicating the likelihood of the lesion being of each particular cancer subtype. Furthermore, the invention extracts importance maps from the classification model, indicating features correlated with each cancer subtype. These maps are visually displayed on a computing device, providing valuable insights for medical professionals.
Career Highlights
Ray Mathew Bradley is currently associated with Infotech Soft, Inc., where he continues to work on innovative solutions in the medical field. His career is marked by a commitment to advancing technology that aids in the diagnosis and treatment of cancer.
Conclusion
Ray Mathew Bradley's contributions to radiogenomics exemplify the intersection of technology and healthcare. His innovative patent has the potential to significantly impact cancer diagnosis and treatment, showcasing the importance of continued research and development in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile